CorMedix (CRMD) Gross Margin (2013 - 2025)

CorMedix's (CRMD) quarterly Gross Margin came in at 83.43% in Q4 2025, down 1280.0% year-on-year from 7.07% in Q4 2024, and down 6.53% quarter-over-quarter from 89.26% in Q3 2025.

CorMedix (CRMD) Gross Margin (2013 - 2025) Analysis & Trends

CorMedix has disclosed Gross Margin across 12 years of filings, most recently posting 83.43% for Q4 2025.

  • Gross Margin for Q4 2025 came in at 83.43%, down 1280.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 88.46% (down 414.0% YoY), and the FY2025 annual result was 88.46%, down 420.0% from the prior year.
  • Gross Margin came in at 83.43% for Q4 2025 at CorMedix, down from 89.26% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 98.63% in Q4 2022 to a low of 76.12% in Q2 2021.
  • The 4-year median for Gross Margin is 83.43% (2025), against an average of 63.31%.
  • Across the five-year window, Gross Margin tumbled 5945 bps in 2021 and soared 17456 bps in 2022, its largest moves.
  • CorMedix's Gross Margin stood at 14.88% in 2021, then soared by 563 bps to 98.63% in 2022, then dropped by 2 bps to 96.24% in 2024, then retreated by 13 bps to 83.43% in 2025.
  • The last three Gross Margin figures came in at 83.43% (Q4 2025), 89.26% (Q3 2025), and 95.31% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 79.04%
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 86.85%
9 Abivax 91.71 Bn 91.71 Bn - -
10 CorMedix 631,378.03 -154.57 Mn 107.31 Mn 83.43%

Historic Data

Download Data
DateValue
Dec 31, 2025 83.43%
Sep 30, 2025 89.26%
Jun 30, 2025 95.31%
Mar 31, 2025 95.91%
Dec 31, 2024 96.24%
Sep 30, 2024 94.01%
Jun 30, 2024 36.75%
Dec 31, 2022 98.63%
Sep 30, 2022 78.45%
Jun 30, 2022 98.44%
Mar 31, 2022 80.00%
Dec 31, 2021 14.88%
Sep 30, 2021 33.93%
Jun 30, 2021 -76.12%
Mar 31, 2021 30.50%
Dec 31, 2020 -2.72%
Sep 30, 2020 14.09%
Jun 30, 2020 -16.67%
Mar 31, 2020 34.48%
Dec 31, 2019 -86.15%